KIDS
OrthoPediatrics Corp.
KIDS has lower modeled downside risk, despite its lower overall score.
OSCR
Oscar Health, Inc.
OSCR has the edge over KIDS overall, supported by stronger fundamentals and stronger modeled upside.
KIDS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Stable | |
| Unavailable |
KIDS's revenue is currently healthy, and its cash flow is stable, but its profitability is under pressure. There isn't enough data to rate its balance sheet.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
KIDS PE Valuation
KIDS has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
KIDS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect KIDS's losses to shrink, with revenue growing.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
KIDS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$1.43 | +$0.53 |
| Q2 2026 | -$1.68 | +$0.12 |
| Q1 2026 | -$1.68 | +$0.08 |
| Q4 2025 | -$1.69 | -$0.05 |
| Q3 2025 | -$1.96 | -$0.73 |
| Q2 2025 | -$1.80 | -$0.71 |
| Q1 2025 | -$1.76 | -$0.80 |
| Q4 2024 | -$1.64 | -$0.72 |
KIDS is still losing money, but less than at its worst: $1.43 per share over the past year, against $2.05 at its worst in early 2021.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over KIDS on earnings quality, reporting a profit while its opponent remains loss making.
KIDS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $72.7M | +19% |
| Q2 2026 | $70.5M | +15% |
| Q1 2026 | $59.4M | +13% |
| Q4 2025 | $61.6M | +17% |
| Q3 2025 | $61.3M | +12% |
| Q2 2025 | $61.1M | +16% |
| Q1 2025 | $52.4M | +17% |
| Q4 2024 | $52.7M | +40% |
KIDS's revenue has grown year over year for 23 quarters in a row: $73M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -5.8% | +9.6 points |
| Q2 2026 | -5.8% | +12 points |
| Q1 2026 | -14% | +6.9 points |
| Q4 2025 | -13% | +13 points |
| Q3 2025 | -15% | -5.2 points |
| Q2 2025 | -17% | -6.7 points |
| Q1 2025 | -21% | +0.8 points |
| Q4 2024 | -27% | -5.3 points |
KIDS's operating margin was −5.8% last quarter, up 9.6 points from the same quarter a year ago, near the top of its range since 2019.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over KIDS on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR has the edge over KIDS on profitability, with a higher operating margin.
KIDS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.6M | +$5M |
| Q2 2026 | -$3.1M | +$10.8M |
| Q1 2026 | -$5M | +$3.3M |
| Q4 2025 | $9.7M | +$13.5M |
| Q3 2025 | -$3.4M | +$8.2M |
| Q2 2025 | -$13.9M | -$1.1M |
| Q1 2025 | -$8.4M | +$4.8M |
| Q4 2024 | -$3.7M | +$7.7M |
KIDS has the edge over OSCR on cash flow, with more consistent year-over-year improvement.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $4.1B over the past year.
KIDS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +105K shares |
| 1 year | +2.5% | +588K shares |
| 3 years | +6.1% | +1.4M shares |
| 5 years | +25% | +4.9M shares |
| Available history | +65% | +9.5M shares |
KIDS has the edge over OSCR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q1 2020 | $187,000 |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has 346M diluted shares, up 34% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
KIDS Net Leverage
KIDS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
KIDS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 78.2 | Overbought |
| Stochastic | 84.8 | Overbought |
KIDS's weekly RSI is 78 (overbought) and its Stochastic is 85 (overbought).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
KIDS PE vs Healthcare Sector
| Metric | KIDS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
KIDS has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
KIDS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.0 | 25% above |
| 20 week MA | $23.5 | 39% above |
| 50 week MA | $19.9 | 64% above |
| 100 week MA | $20.6 | 58% above |
| 200 week MA | $27.3 | 19% above |
KIDS has climbed back above all five of its weekly moving averages, and it's now 19% above its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR is in an uptrend: it's above all five of its weekly moving averages, and 106% above its 200-week average.
KIDS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.5 | $46.3 | -0.4% |
| 2021 | $46.3 | $60.8 | +31% |
| 2022 | $60.8 | $38.0 | -37% |
| 2023 | $38.0 | $32.5 | -14% |
| 2024 | $32.5 | $22.9 | -30% |
| 2025 | $22.9 | $17.3 | -24% |
| 2026 YTD | $17.3 | $32.6 | +88% |
KIDS has finished four years in a row lower, and it's up 88% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over KIDS on returns for 2026, with the stronger performance.